EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

A Bibenzyl from Dendrobium pachyglossum Exhibits Potent Anti-Cancer Activity Against Glioblastoma Multiforme

Hnin Mon Aung, Onsurang Wattanathamsan, Kittipong Sanookpan, Aphinan Hongprasit, Chawanphat Muangnoi iD, Rianthong Phumsuay, Thanawan Rojpitikul, Boonchoo Sritularak iD, Tankun Bunlue, Naphat Chantaravisoot iD, Claudia R Oliva, Corinne E Griguer and 1 more

Antioxidants · 2025-10-07 · 14 (10) · 1212

DOI: 10.3390/antiox14101212 ↗

At a glance

Journal article in Antioxidants, published online on 2025-10-07. Written by Hnin Mon Aung and 12 co-authors. Institution: Pharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand. Cited 3 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Research Council of Thailand (NRCT) and Chulalongkorn University, Second Century Fund (C2F), Chulalongkorn University, the Faculty of Pharmaceutical Sciences, Chulalongkorn University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Glioblastoma multiforme (GBM) is an aggressive brain tumor with limited treatment options and a poor prognosis. Natural phytochemicals from Dendrobium species, particularly bibenzyl derivatives, possess diverse pharmacological activities, yet their potential against GBM remains largely unexplored. Here, we investigated the anticancer activity of 4,5,4′-trihydroxy-3,3′-dimethoxybibenzyl (TDB), a potent antioxidant bibenzyl derivative isolated from Dendrobium pachyglossum. In U87MG cells, TDB reduced viability in a dose- and time-dependent manner, suppressed clonogenic growth, induced apoptosis via Bax upregulation and Bcl-xL/Mcl-1 downregulation, and inhibited both mTORC1 and mTORC2 signaling. TDB also impaired cell migration and downregulated epithelial–mesenchymal transition (EMT)-associated proteins. Notably, TDB enhanced the cytotoxicity of temozolomide (TMZ), the current standard of care for GBM. These TMZ-sensitizing properties were further confirmed in patient-derived xenograft (PDX) Jx22 cells. To assess its potential for central nervous system delivery, blood–brain barrier (BBB) permeability was predicted using four independent in silico platforms—ADMETlab 3.0, LogBB_Pred, LightBBB, and BBB Predictor (Tree2C)—all of which consistently classified TDB as BBB-permeable. This predicted CNS accessibility, together with its potent anticancer profile, underscores TDB’s translational promise. Collectively, our findings identify TDB as a plant-derived antioxidant with multifaceted anti-GBM activity and favorable BBB penetration potential, warranting further in vivo validation and preclinical development as a novel therapeutic candidate for GBM.

Subjects

Author keywords

Dendrobiumanti-cancerbibenzylglioblastomaphytochemical

Authors and institutions

  • Pharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Biological Science and Animal Model Unit, Institute of Nutrition, Mahidol University, Nakhon Pathom 73170, Thailand.
  • Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Center of Excellence in Natural Products for Ageing and Chronic Diseases, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.

ORCID profiles: Chawanphat Muangnoi, Boonchoo Sritularak, Naphat Chantaravisoot, Visarut Buranasudja

Funding

  • National Research Council of Thailand (NRCT) and Chulalongkorn University
  • Second Century Fund (C2F), Chulalongkorn University
  • the Faculty of Pharmaceutical Sciences, Chulalongkorn University

Cite

APA

Aung, H. M., Wattanathamsan, O., Sanookpan, K., Hongprasit, A., Muangnoi, C., Phumsuay, R., Rojpitikul, T., Sritularak, B., Bunlue, T., Chantaravisoot, N., Oliva, C. R., Griguer, C. E., & Buranasudja, V. (2025). A Bibenzyl from Dendrobium pachyglossum Exhibits Potent Anti-Cancer Activity Against Glioblastoma Multiforme. Antioxidants, 14(10), 1212. https://doi.org/10.3390/antiox14101212

Vancouver

Aung HM, Wattanathamsan O, Sanookpan K, Hongprasit A, Muangnoi C, Phumsuay R, et al. A Bibenzyl from Dendrobium pachyglossum Exhibits Potent Anti-Cancer Activity Against Glioblastoma Multiforme. Antioxidants. 2025;14(10):1212. doi:10.3390/antiox14101212

BibTeX
@article{Aung2025,
  author = {Aung, Hnin Mon and Wattanathamsan, Onsurang and Sanookpan, Kittipong and Hongprasit, Aphinan and Muangnoi, Chawanphat and Phumsuay, Rianthong and Rojpitikul, Thanawan and Sritularak, Boonchoo and Bunlue, Tankun and Chantaravisoot, Naphat and Oliva, Claudia R and Griguer, Corinne E and Buranasudja, Visarut},
  title = {A Bibenzyl from Dendrobium pachyglossum Exhibits Potent Anti-Cancer Activity Against Glioblastoma Multiforme},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {1212},
  doi = {10.3390/antiox14101212}
}
Start for free →